{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:52:03Z","timestamp":1790790723987,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,29]]},"DOI":"10.7759\/cureus.111765","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:25:54Z","timestamp":1782782754000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Class III Lupus Nephritis With Concurrent Thrombotic Microangiopathy and Suspected Atypical Hemolytic Uremic Syndrome Requiring Complement Blockade: A Complex Multisystem Presentation"],"prefix":"10.7759","author":[{"given":"Nishma","family":"Pokharel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsalan","family":"Alvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.10.017","article-title":"Update on lupus nephritis: core curriculum 2020","volume":"76","author":"Parikh SV","year":"2020","unstructured":"Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020, 76:265-81. 10.1053\/j.ajkd.2019.10.017","journal-title":"Am J Kidney Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2024.06.202731","article-title":"[Lupus nephritis and thrombotic microangiopathy: a review]","volume":"96","author":"Bobrova LA","year":"2024","unstructured":"Bobrova LA, Kozlovskaya NL. [Lupus nephritis and thrombotic microangiopathy: a review]. Ter Arkh. 2024, 96:628-34. 10.26442\/00403660.2024.06.202731","journal-title":"Ter Arkh"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-01888-5","article-title":"A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy","volume":"21","author":"Wright RD","year":"2020","unstructured":"Wright RD, Bannerman F, Beresford MW, Oni L. A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy. BMC Nephrol. 2020, 21:245. 10.1186\/s12882-020-01888-5","journal-title":"BMC Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1081942","article-title":"Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation","volume":"13","author":"Zhang B","year":"2022","unstructured":"Zhang B, Xing G. Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation. Front Immunol. 2022, 13:1081942. 10.3389\/fimmu.2022.1081942","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02293-2","article-title":"Eculizumab therapy on a patient with co-existent lupus nephritis and C3 mutation-related atypical haemolytic uremic syndrome: a case report","volume":"22","author":"Kim MJ","year":"2021","unstructured":"Kim MJ, Lee H, Kim YH, Jin SY, Kim HJ, Oh D, Jeon JS. Eculizumab therapy on a patient with co-existent lupus nephritis and C3 mutation-related atypical haemolytic uremic syndrome: a case report. BMC Nephrol. 2021, 22:86. 10.1186\/s12882-021-02293-2","journal-title":"BMC Nephrol"},{"key":"ref6","article-title":"[Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy]","volume":"37","author":"Fani FM","year":"2020","unstructured":"Fani FM, Patera A, Delsante M, et al.. [Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy]. G Ital Nefrol. 2020, 37:1-14.","journal-title":"G Ital Nefrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.07.031","article-title":"Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab","volume":"65","author":"El-Husseini A","year":"2015","unstructured":"El-Husseini A, Hannan S, Awad A, Jennings S, Cornea V, Sawaya BP. Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab. Am J Kidney Dis. 2015, 65:127-30. 10.1053\/j.ajkd.2014.07.031","journal-title":"Am J Kidney Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018019596","article-title":"Complement-mediated thrombotic microangiopathy associated with lupus nephritis","volume":"2","author":"Park MH","year":"2018","unstructured":"Park MH, Caselman N, Ulmer S, Weitz IC. Complement-mediated thrombotic microangiopathy associated with lupus nephritis. Blood Adv. 2018, 2:2090-4. 10.1182\/bloodadvances.2018019596","journal-title":"Blood Adv"},{"key":"ref9","article-title":"Thrombotic microangiopathy in lupus nephritis patients","volume":"22","author":"Kotb HA","year":"2016","unstructured":"Kotb HA, Mokbel AN, Elmaghraby AA, Fadda SAE. Thrombotic microangiopathy in lupus nephritis patients. Kasr Al Ainy Med J. 2016, 22:12.","journal-title":"Kasr Al Ainy Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf326","article-title":"Renal thrombotic microangiopathy impairs renal function recovery in lupus nephritis","volume":"18","author":"Zhang M","year":"2025","unstructured":"Zhang M, Zhang X, Xiang W, et al.. Renal thrombotic microangiopathy impairs renal function recovery in lupus nephritis. Clin Kidney J. 2025, 18:sfaf326. 10.1093\/ckj\/sfaf326","journal-title":"Clin Kidney J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05499-1","article-title":"Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis","volume":"40","author":"Mejia-Vilet JM","year":"2021","unstructured":"Mejia-Vilet JM, G\u00f3mez-Ruiz IA, Cruz C, et al.. Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis. Clin Rheumatol. 2021, 40:2233-42. 10.1007\/s10067-020-05499-1","journal-title":"Clin Rheumatol"},{"key":"ref12","article-title":"A clinical approach of lupus nephritis associated with catastrophic antiphospholipid-antibody syndrome review and case report","volume":"12","author":"Stoian M","year":"2022","unstructured":"Stoian M. A clinical approach of lupus nephritis associated with catastrophic antiphospholipid-antibody syndrome review and case report. Int J Clin Case Rep Rev. 2022, 12:1-6.","journal-title":"Int J Clin Case Rep Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/08916930400022616","article-title":"Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?","volume":"38","author":"Riboldi P","year":"2005","unstructured":"Riboldi P, Gerosa M, Moroni G, et al.. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?. Autoimmunity. 2005, 38:39-45. 10.1080\/08916930400022616","journal-title":"Autoimmunity"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.IJN_204_16","article-title":"Lupus nephritis with coexistent antiphospholipid antibodies associated nephropathy: a case report and literature review","volume":"28","author":"Talari K","year":"2018","unstructured":"Talari K, Anandh U, Patrick A. Lupus nephritis with coexistent antiphospholipid antibodies associated nephropathy: a case report and literature review. Indian J Nephrol. 2018, 28:164-6. 10.4103\/ijn.IJN_204_16","journal-title":"Indian J Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446758-severe-class-iii-lupus-nephritis-with-concurrent-thrombotic-microangiopathy-and-suspected-atypical-hemolytic-uremic-syndrome-requiring-complement-blockade-a-complex-multisystem-presentation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:25:55Z","timestamp":1782782755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446758-severe-class-iii-lupus-nephritis-with-concurrent-thrombotic-microangiopathy-and-suspected-atypical-hemolytic-uremic-syndrome-requiring-complement-blockade-a-complex-multisystem-presentation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.111765","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}